文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

1996 - 2022年巴西肝脏疾病负担:一项关于流行病学及对公共医疗影响的回顾性描述性研究

Burden of liver disease in Brazil, 1996-2022: a retrospective descriptive study of the epidemiology and impact on public healthcare.

作者信息

Guimarães João Sérgio Fonseca, Mesquita Jordana Almeida, Kimura Thais Yuki, Oliveira Ana Luíza Matos, Leite M Fatima, Oliveira André Gustavo

机构信息

Department of Physiology and Biophysics, Institute of Biological Science, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.

School of Medicine, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.

出版信息

Lancet Reg Health Am. 2024 Apr 19;33:100731. doi: 10.1016/j.lana.2024.100731. eCollection 2024 May.


DOI:10.1016/j.lana.2024.100731
PMID:38800645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11117060/
Abstract

BACKGROUND: Liver disease is a major cause of mortality and morbidity worldwide and its epidemiology depends on the genetic background, exposure to risk factors, access to healthcare and other sociodemographic characteristics. Brazil is a large country with diverse multicultural and ethnic heritages and important socioeconomic inequalities. The burden of liver disease in Brazil, its regions and population is unknown. METHODS: We retrieved data from the Unified Health System regarding liver diseases and analyzed the mortality and morbidity from 1996 to 2022 by gender, race/ethnicity, age, region and overall. We calculated the age-specific risk of deaths by liver disease, age-standardization of the data, mean hospitalization and liver transplant-associated costs. FINDINGS: Malignant neoplasm of the liver and intrahepatic bile ducts, alcohol-associated liver disease, fibrosis, and cirrhosis of the liver, other diseases of the liver, hepatic failure, chronic viral hepatitis were identified as the major causes of death and morbidity in Brazil in the period analyzed. The epidemiology of these diseases was diverse, with variations according to geographic regions, gender and race/ethnicity. The major economic burden of liver disease is related to liver transplants, a common outcome of the progression of these diseases. INTERPRETATION: Liver disease in Brazil is a serious issue for the public health system due to the high number of deaths and increasing mortality rate. Our study contributes as a necessary prerequisite for the development of tailored public health policies aimed at mitigating the increasing burden of liver diseases in specific populations and regions. FUNDING: CNPq, INCT, CAPES, FAPEMIG.

摘要

背景:肝脏疾病是全球死亡和发病的主要原因,其流行病学取决于遗传背景、风险因素暴露、医疗保健可及性以及其他社会人口学特征。巴西是一个大国,拥有多元的文化和种族遗产以及严重的社会经济不平等。巴西及其各地区和人口中肝脏疾病的负担尚不清楚。 方法:我们从统一卫生系统中检索了有关肝脏疾病的数据,并按性别、种族/民族、年龄、地区和总体情况分析了1996年至2022年的死亡率和发病率。我们计算了肝脏疾病的年龄特异性死亡风险、数据的年龄标准化、平均住院时间以及与肝移植相关的费用。 研究结果:在分析期内,肝和肝内胆管恶性肿瘤、酒精性肝病、肝纤维化和肝硬化、其他肝脏疾病、肝衰竭、慢性病毒性肝炎被确定为巴西死亡和发病的主要原因。这些疾病的流行病学各不相同,因地理区域、性别和种族/民族而异。肝脏疾病的主要经济负担与肝移植有关,这是这些疾病进展的常见结果。 解读:由于死亡人数众多和死亡率不断上升,巴西的肝脏疾病对公共卫生系统来说是一个严重问题。我们的研究为制定针对性的公共卫生政策做出了贡献,这些政策旨在减轻特定人群和地区日益增加的肝脏疾病负担。 资金来源:巴西国家科学技术发展委员会、国家科技创新研究所、巴西高等教育人员素质提升协调办公室、米纳斯吉拉斯州研究资助基金会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/816e1500c276/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/f34cb24838ef/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/46d4a25f2de4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/cbb91125251a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/43f27fd70bcb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/816e1500c276/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/f34cb24838ef/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/46d4a25f2de4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/cbb91125251a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/43f27fd70bcb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf92/11117060/816e1500c276/gr5.jpg

相似文献

[1]
Burden of liver disease in Brazil, 1996-2022: a retrospective descriptive study of the epidemiology and impact on public healthcare.

Lancet Reg Health Am. 2024-4-19

[2]
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Lancet Gastroenterol Hepatol. 2020-1-22

[3]
Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study.

Ann Hepatol. 2017

[4]
Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the "Global Burden of Disease 2017" (GBD 2017) study.

Popul Health Metr. 2020-9-30

[5]
Burden of liver disease in Brazil.

Liver Int. 2014-7

[6]
Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study.

Lancet Glob Health. 2020-7-2

[7]
All-cause and cause-specific mortality among people with severe mental illness in Brazil's public health system, 2000-15: a retrospective study.

Lancet Psychiatry. 2022-10

[8]
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[9]
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].

Epidemiol Prev. 2023

[10]
Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019.

BMC Public Health. 2024-2-3

引用本文的文献

[1]
Proportional mortality and years of potential life lost due to liver diseases among agricultural workers, Brazil, 2017 to 2022.

Cad Saude Publica. 2025-1-27

[2]
Clinical outcomes of COVID-19 in patients with liver cirrhosis - a propensity-matched analysis from a multicentric Brazilian cohort.

BMC Infect Dis. 2025-1-15

[3]
Ensuring scientific rigour: essential recommendations on how to identify prior evidence in medicine-author's response.

Lancet Reg Health Am. 2024-5-30

[4]
Ensuring scientific rigor: essential recommendations on how to identify prior evidence in medicine.

Lancet Reg Health Am. 2024-5-21

本文引用的文献

[1]
Liver transplantation in Latin America: reality and challenges.

Lancet Reg Health Am. 2023-11-18

[2]
Tackling the burden of preventable liver disease in the USA.

Lancet Gastroenterol Hepatol. 2024-1

[3]
Global burden of liver disease: 2023 update.

J Hepatol. 2023-8

[4]
Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico.

Lancet Reg Health Am. 2021-12-21

[5]
Quantifying the Negative Impact of Fast-food Consumption on Liver Steatosis Among United States Adults With Diabetes and Obesity.

Clin Gastroenterol Hepatol. 2023-11

[6]
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.

Clin Mol Hepatol. 2022-10

[7]
Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement.

Curr Treat Options Gastroenterol. 2022

[8]
The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas.

Lancet Gastroenterol Hepatol. 2022-6

[9]
Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis.

Ann Hepatol. 2022

[10]
Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma.

JHEP Rep. 2021-5-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索